Readmissions after major urologic cancer surgery

Area of Science:

• Urology
• Surgical Oncology
• Health Services Research

Background:

• Major urologic cancer surgeries include radical prostatectomy (RP), radical nephrectomy (RNx), partial nephrectomy (PNx), and radical cystectomy (RC).
• Readmission after major surgery is a critical quality indicator in surgical care.

Purpose of the Study:

• To examine the incidence and predictors of 30-day readmission after major urologic cancer surgery.
• To identify patient characteristics associated with increased readmission risk.

Main Methods:

• Utilized the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) database for 2011.
• Included patients undergoing RP, RNx, PNx, and RC.
• Employed multivariable logistic regression to analyze readmission predictors.

Main Results:

• Readmission rates varied by procedure: RP (3.8%), RNx (6.8%), PNx (6.3%), and RC (20.7%).
• Predictors for RP readmission included age, higher American Society of Anesthesiology (ASA) score, smoking, and complications (wound, thromboembolic, renal failure).
• For RC, only age predicted readmission. For RNx, higher ASA score and index hospitalization complications were significant predictors.

Conclusions:

• Patient characteristics significantly influence 30-day readmission risk following major urologic cancer surgery.
• Focusing on preventing and managing intraoperative complications can substantially lower readmission rates.